logo

Surface Oncology, Inc. (SURF)



Trade SURF now with
  Date
  Headline
3/10/2020 6:36:06 AM Surface Oncology Q4 Net Loss $16.0 Mln Or $0.57/Shr Vs Loss $4.7 Mln Or $0.17/Shr Last Year
1/27/2020 4:25:16 PM Surface Oncology Says FDA Cleared IND Applications For Its Antibody Candidates, SRF617 And SRF388
11/25/2019 8:13:40 AM Surface Oncology Secures Debt Financing Facility For Up To $25 Mln From K2 HealthVentures
11/18/2019 6:51:55 AM Surface Oncology Submits IND Application To Support Initiation Of Phase 1/1b Clinical Study Of SRF617
9/3/2019 7:05:22 AM Surface Oncology Adds Ramy Ibrahim To Board
8/7/2019 6:21:37 AM Surface Oncology Q2 Net Loss $17.8 Mln Or $0.64/Shr
4/1/2019 7:10:28 AM Surface Oncology Appoints Wendy Dwyer As Chief Business Officer
3/7/2019 4:09:36 PM Surface Oncology Q4 Loss/share $0.17 Vs. Loss $6.16 Year Ago
1/4/2019 7:02:38 AM Surface Oncology Appoints Stephen Hodi To Scientific Advisory Board
11/13/2018 6:49:26 AM Surface Oncology Q3 Net Loss $17.2 Mln Or $0.62/Shr Vs Loss $14.4 Mln Or $5.75/Shr Last Year
6/12/2018 7:06:24 AM Surface Oncology Begins Phase I Clinical Trial Of SRF373 / NZV930